loading...| Preferred Name |
papillary thyroid cancer |
|
| Synonyms |
Papillary Cancer of Thyroid Thyroid Papillary Carcinoma |
|
| Definitions |
A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. It is linked to radiation exposure and is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries. Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound, and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance. Depending on the size and spread of the disease, surgical options include lobectomy, and partial or complete thyroidectomy. Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C4035" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C4035" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000040217 |
|
| altLabel |
Papillary Cancer of Thyroid Papillary Carcinoma of the Thyroid Papillary Thyroid Carcinoma Papillary Carcinoma of the Thyroid Gland Thyroid Gland Papillary Carcinoma Papillary Cancer of the Thyroid Papillary Carcinoma of Thyroid Gland Papillary Cancer of Thyroid Gland Papillary Carcinoma of Thyroid Papillary Thyroid Gland Carcinoma thyroid cancer, papillary Papillary Cancer of the Thyroid Gland Thyroid Papillary Carcinoma |
|
| cui |
C0238463 |
|
| definition |
A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. It is linked to radiation exposure and is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries. Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound, and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance. Depending on the size and spread of the disease, surgical options include lobectomy, and partial or complete thyroidectomy. Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C4035" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C4035" NCI Thesaurus) |
|
| Legacy PDQ ID |
3025 |
|
| MENU PARENT |
thyroid cancer |
|
| MENU TYPE |
Clinical Trials--CancerType |
|
| NCI ID |
C4035 |
|
| notation |
CDR0000040217 |
|
| ORIG STY |
Cancer stage |
|
| prefLabel |
papillary thyroid cancer |
|
| tui |
T191 |
|
| subClassOf |